Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Russell, K. Heesom, S. Hall, S. Johnston, P. Barnes, I. Adcock (London, Bristol, Stevenage, United Kingdom). LATE-BREAKING ABSTRACT: Stable isotope labelled amino acid culturing: a novel approach to identify pathways involved in MIF signalling. Eur Respir J 2013; 42: Suppl. 57, 670

Member's Comments

No comment yet.

Related content which might interest you: Characterizations and potential functions of protein arginine methyltransferase 1 in primary lung structural cells Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Notch signalling in human basophils Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 LATE-BREAKING ABSTRACT: Genapha/dbASM: investigating allele-specific methylation (ASM) and associations to common complex diseases Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 INTS12 knockdown leads to perturbation of genes and pathways of relevance to airway biology Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 LATE-BREAKING ABSTRACT: S-nitrosylation of Ran-binding protein 3 in the human airway: use of a novel protein microarray technology Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Expression and function of a novel membrane-spanning protein, MS4A8B, in the human airways Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 New outlook on the Th1/Th2-alternative signaling pathways in asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 LATE-BREAKING ABSTRACT: The effect of fibre, gut microbiota and short-chain fatty acids on the development of asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 The effect of a novel phosphoinositide 3-kinase Δ inhibitor (PI3KΔ), GSK2269557, on potential biomarkers measured from the lungs of healthy male smokers Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Validation of the pitavastatin-induced angiomotin-like protein 1 that controls tight junction stability of lung microvascular endothelial cells via LKB1/AMPK activation Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015